Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Acq. announced
ANI PHARMACEUTICALS INC (ANIP) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 144 Form 144 - Report of proposed sale of securities:
10/02/2023 8-K Quarterly results
08/23/2023 8-K Appointed a new director
Docs: "ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors"
08/18/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 SC 13D/A Meridian Venture Partners II GP, L.P. reports a 9.2% stake in ANI Pharmaceuticals, Inc.
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
07/21/2023 144 Form 144 - Report of proposed sale of securities:
07/20/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/18/2023 144 Form 144 - Report of proposed sale of securities:
07/17/2023 144 Form 144 - Report of proposed sale of securities:
07/14/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Investor Presentation, dated June 2023"
05/25/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/16/2023 8-K Asset disposition
Docs: "Opinion of Morgan, Lewis & Bockius LLP",
"ANI PHARMACEUTICALS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK INCLUDING FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES"
05/12/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/12/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement, by and between ANI Pharmaceuticals, Inc. and Guggenheim Securities, LLC",
"ANI PHARMACEUTICALS ANNOUNCES PRICING OF $75 MILLION PUBLIC OFFERING OF COMMON STOCK"
05/11/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ANI PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK"
05/11/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/08/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/08/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance"
03/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
03/09/2023 10-K Annual Report for the period ended December 31, 2022
03/09/2023 8-K Quarterly results
Docs: "ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy